Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | OGG1 | O15527 | 1/20 | 0.45 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.44 |
| ▸ | KLK7 | P49862 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | F9 | P00740 | 1/20 | 0.42 |
| ▸ | PLAU | P00749 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10421096 | 0.88 | STS (0.52) | ESR1ESR2MEN1KMT2AMAPT | |
| SCHEMBL1454525 | 0.83 | L3MBTL1 (0.57) | CYP3A4TSHRALDH2ALDH1A1CHRNB4 | |
| SCHEMBL13070034 | 0.83 | CYP3A4 (0.49) | CYP3A4ESR1ESR2TSHRALDH1A1 | |
| SCHEMBL27566569 | 0.83 | ABL1 (0.53) | ESR1TSHRKLK7MEN1KMT2A | |
| SCHEMBL14121601 | 0.83 | TP53 (0.52) | CYP3A4TSHRALDH2ALDH1A1OGG1 | |
| SCHEMBL14121604 | 0.83 | TP53 (0.52) | CYP3A4TSHRALDH2ALDH1A1OGG1 | |
| SCHEMBL14122295 | 0.83 | TP53 (0.52) | CYP3A4TSHRALDH2ALDH1A1OGG1 | |
| SCHEMBL10421809 | 0.82 | CLK1 (0.50) | ALDH1A1MEN1KMT2AMAPTHPGD | |
| SCHEMBL9559199 | 0.82 | CYP1A2 (0.56) | CYP3A4ESR1ESR2TSHRALDH1A1 | |
| SCHEMBL839599 | 0.82 | CYP1A2 (0.55) | TSHRALDH1A1KLK7MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12378205-B2 | Process for the preparation of triazine intermediates and a process for the preparation of UV absorbers thereof | BASF SE (DE) | 2025-08-05 | — | — | US | disclosed |
| US-12291509-B2 | Process for the preparation of UV absorbers | BASF SE (DE) | 2025-05-06 | — | — | US | disclosed |
| EP-3908576-B1 | A PROCESS FOR THE PREPARATION OF UV ABSORBERS | BASF SE (DE) | 2023-03-08 | — | — | EP | disclosed |
| US-20220119357-A1 | A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| US-20220064129-A1 | A PROCESS FOR THE PREPARATION OF UV ABSORBERS | BASF CHEMICALS INDIA PVT. LTD. (IN) | 2022-03-03 | — | — | US | disclosed |
| EP-3908633-A1 | A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF | BASF SE (DE) | 2021-11-17 | — | — | EP | disclosed |
| EP-3908576-A1 | A PROCESS FOR THE PREPARATION OF UV ABSORBERS | BASF SE (DE) | 2021-11-17 | — | — | EP | disclosed |
| CN-113260679-A | Process for preparing triazine intermediates and process for preparing UV absorbers thereof | 巴斯夫欧洲公司 | 2021-08-13 | — | — | CN | disclosed |
| CN-113260611-A | Method for producing UV absorbers | 巴斯夫欧洲公司 | 2021-08-13 | — | — | CN | disclosed |
| WO-2020144094-A1 | A PROCESS FOR THE PREPARATION OF UV ABSORBERS | BASF SE (DE) | 2020-07-16 | — | — | WO | disclosed |
| US-7629372-B2 | Compounds for the treatment of dyslipidemia and other lipid disorders | MERCK & CO., INC. (US) | 2009-12-08 | — | — | US | disclosed |
| US-7629372-B2 | Compounds for the treatment of dyslipidemia and other lipid disorders | MERCK & CO., INC. (US) | 2009-12-08 | — | — | US | disclosed |
| US-20080039514-A1 | Compounds for the Treatment of Dyslipidemia and Other Lipid Disorders | MERCK & CO., INC. (US) | 2008-02-14 | — | — | US | disclosed |
| US-20080039514-A1 | Compounds for the Treatment of Dyslipidemia and Other Lipid Disorders | MERCK & CO., INC. (US) | 2008-02-14 | — | — | US | disclosed |
| CN-1151696-A | Antibacterial agent | DAIICHI SEIYAKU CO (JP) | 1997-06-11 | — | — | CN | disclosed |
| EP-0768085-A1 | ANTIBACTERIAL AGENT | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1997-04-16 | — | — | EP | disclosed |
| EP-0761215-A1 | ANTIBACTERIAL AGENT | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1997-03-12 | — | — | EP | disclosed |
| EP-0537538-A1 | Derivatives of fluorinated phenoxyphenoxycarboxylic acid as herbicides | BAYER AG (DE) | 1993-04-21 | — | — | EP | disclosed |
| US-4962203-A | ANTIASTHMATIC, ANTIALLERGENIC, ANTIINFLAMMATORY AND CYTOPROTECTIVE AGENTS | MERCK FROST CANADA, INC. (CA) | 1990-10-09 | — | — | US | disclosed |
| EP-0206751-A2 | 2-Substituted quinolines, their preparation and use | MERCK FROSST CANADA INC. (CA) | 1986-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119357-A1 | A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF | DHPS, NISCH, UNG | CYP3A4 36/4885ESR1 3476/4885ESR2 3392/4885 |
| US-12378205-B2 | Process for the preparation of triazine intermediates and a process for the preparation of UV absorbers thereof | DHPS, UNG, UMPS | CYP3A4 28/4885ESR1 3125/4885ESR2 3273/4885 |
| US-20080039514-A1 | Compounds for the Treatment of Dyslipidemia and Other Lipid Disorders | LIPA, APOB, LCAT | CYP3A4 818/4885ESR1 4422/4885ESR2 2327/4885 |
| US-20220064129-A1 | A PROCESS FOR THE PREPARATION OF UV ABSORBERS | UNG, ERCC4, UROD | CYP3A4 165/4885ESR1 2540/4885ESR2 2883/4885 |
| US-12291509-B2 | Process for the preparation of UV absorbers | UNG, UROD, ERCC4 | CYP3A4 66/4885ESR1 2594/4885ESR2 3010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.